American Century Companies Inc. Has $33.34 Million Stock Position in SI-BONE, Inc. (NASDAQ:SIBN)

American Century Companies Inc. raised its stake in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 11.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,378,068 shares of the company's stock after acquiring an additional 236,167 shares during the quarter. American Century Companies Inc. owned approximately 5.67% of SI-BONE worth $33,341,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. FMR LLC boosted its holdings in shares of SI-BONE by 103.6% in the 3rd quarter. FMR LLC now owns 2,354 shares of the company's stock valued at $33,000 after buying an additional 1,198 shares during the period. Rhumbline Advisers lifted its holdings in SI-BONE by 3.0% in the fourth quarter. Rhumbline Advisers now owns 57,621 shares of the company's stock worth $808,000 after purchasing an additional 1,683 shares during the period. Franklin Resources Inc. boosted its holdings in shares of SI-BONE by 9.4% in the third quarter. Franklin Resources Inc. now owns 20,220 shares of the company's stock valued at $265,000 after acquiring an additional 1,745 shares in the last quarter. Mainstream Capital Management LLC acquired a new position in shares of SI-BONE during the 4th quarter valued at $53,000. Finally, R Squared Ltd acquired a new position in SI-BONE during the fourth quarter worth about $73,000. Institutional investors own 98.11% of the company's stock.

Insider Activity at SI-BONE

In other SI-BONE news, CFO Anshul Maheshwari sold 5,304 shares of the business's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $13.91, for a total value of $73,778.64. Following the completion of the sale, the chief financial officer now owns 189,319 shares of the company's stock, valued at $2,633,427.29. The trade was a 2.73 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Anthony J. Recupero sold 3,670 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total value of $51,013.00. Following the sale, the insider now directly owns 222,814 shares of the company's stock, valued at $3,097,114.60. The trade was a 1.62 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 9,311 shares of company stock valued at $130,356. 3.90% of the stock is owned by corporate insiders.

Remove Ads

Analysts Set New Price Targets

SIBN has been the topic of several research reports. Needham & Company LLC upped their price target on SI-BONE from $20.00 to $24.00 and gave the company a "buy" rating in a report on Tuesday, February 25th. Cantor Fitzgerald restated an "overweight" rating and set a $25.00 price target on shares of SI-BONE in a report on Tuesday, February 25th. Finally, Truist Financial reaffirmed a "buy" rating and issued a $22.00 price objective (up previously from $18.00) on shares of SI-BONE in a research note on Tuesday, February 25th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $24.40.

SI-BONE Stock Up 2.3 %

Shares of NASDAQ SIBN traded up $0.32 during mid-day trading on Wednesday, reaching $14.36. The company had a trading volume of 374,385 shares, compared to its average volume of 360,003. The stock has a fifty day moving average of $16.25 and a two-hundred day moving average of $14.74. SI-BONE, Inc. has a 12-month low of $11.70 and a 12-month high of $19.16. The company has a market capitalization of $609.63 million, a price-to-earnings ratio of -15.61 and a beta of 1.17. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25.

SI-BONE (NASDAQ:SIBN - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.05. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. The business had revenue of $49.00 million during the quarter, compared to analyst estimates of $48.87 million. As a group, equities research analysts expect that SI-BONE, Inc. will post -0.78 EPS for the current year.

SI-BONE Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.